Results 241 to 250 of about 311,440 (293)

Chimeric Antigen Receptor T‐Cells in Myasthenia Gravis: Advances, Safety Challenges, and Future Directions

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT This review examines the emerging application of chimeric antigen receptor (CAR) T‐cell therapy in myasthenia gravis (MG), with emphasis on safety, efficacy signals, and future therapeutic potential in treatment‐refractory disease. A comprehensive literature search was conducted across PubMed, medRxiv, bioRxiv, and Google Scholar for studies ...
Tobias Hegelmaier   +7 more
wiley   +1 more source

NK cell adoptive transfer in acute myeloid leukemia: a systematic review and meta-analysis. [PDF]

open access: yesFront Immunol
Grassi LDV   +11 more
europepmc   +1 more source

In Utero HSC Transplantation for Sickle Cell Disease: A Potential Therapeutic Approach That Overcomes Complications of Current Therapies

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Sickle cell disease (SCD) affects millions worldwide but has limited treatment options, most of which carry significant side effects. At present, the only curative treatment for SCD is allogeneic or gene‐modified autologous hematopoietic stem cell (HSC) transplantation (Tx).
Oluwaseun O. Babatunde   +4 more
wiley   +1 more source

Guillain–Barre Syndrome With Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Chin‐Mu Hsu   +3 more
wiley   +1 more source

Role of Non-coding RNAs in Acute Myeloid Leukemia. [PDF]

open access: yesNoncoding RNA
Maurya SS, Maurya S, Chaturvedi SK.
europepmc   +1 more source

Home - About - Disclaimer - Privacy